A Randomized, Double-Blind, Placebo-Controlled Study to Assess the Safety and Efficacy of KRP-104 in Patients With Type 2 Diabetes Inadequately Controlled on Metformin Alone.
Phase of Trial: Phase II
Latest Information Update: 24 Dec 2013
At a glance
- Drugs KRP 104 (Primary)
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Sponsors ActivX Biosciences
- 31 Aug 2018 Biomarkers information updated
- 24 Dec 2013 Treatment table added.
- 16 Oct 2009 Additional lead trial investigators identified as reported by ClinicalTrials.gov.